The pharmacist, rare diseases and orphan medicines
Keywords:
Medicamentos huérfanos. Enfermedades raras. Gestión. Atención farmacéutica.Abstract
Treatment of rare diseases is often complicated due to the difficulties posed by the research and development of medicines by the pharmacological industry. One of the greatest concerns of this group of patients, which is both scarce and diverse, is access to available medicines. The European Medicine Agency establishes the term orphan medicines and the incentives and bases for their commercialisation. Due to their special characteristics, the majority of orphan medicines require suitable vigilance and control. The hospital pharmacy services are actively involved in their management and supply, as well as in a correct pharmacotherapeutic monitoring of the patients.Downloads
Download data is not yet available.
Downloads
Published
2008-10-07
How to Cite
1.
Nagore C, Lacalle E, Arteche L. The pharmacist, rare diseases and orphan medicines. An Sist Sanit Navar [Internet]. 2008 Oct. 7 [cited 2025 Dec. 19];31:´127-143. Available from: https://recyt.fecyt.es/index.php/ASSN/article/view/1970
Issue
Section
Research articles
License
La revista Anales del Sistema Sanitario de Navarra es publicada por el Departamento de Salud del Gobierno de Navarra (España), quien conserva los derechos patrimoniales (copyright ) sobre el artículo publicado y favorece y permite la difusión del mismo bajo licencia Creative Commons Reconocimiento-CompartirIgual 4.0 Internacional (CC BY-SA 4.0). Esta licencia permite copiar, usar, difundir, transmitir y exponer públicamente el artículo, siempre que siempre que se cite la autoría y la publicación inicial en Anales del Sistema Sanitario de Navarra, y se distinga la existencia de esta licencia de uso.
